To hear about similar clinical trials, please enter your email below
Trial Title:
Application of LARS Ligament in Bone Prosthesis Replacement
NCT ID:
NCT05616182
Condition:
Malignant Tumor
Conditions: Official terms:
Neoplasms
Study type:
Observational
Overall status:
Not yet recruiting
Study design:
Time perspective:
Prospective
Intervention:
Intervention type:
Other
Intervention name:
LARS ligament and bone prosthesis replacement was performed
Description:
To report the postoperative complications and limb function of patients who underwent
LARS ligament and bone prosthesis replacement in Henan Cancer Hospital.
Arm group label:
LARS ligament and bone prosthesis replacement was performed
Summary:
This is a single-center, prospective, real-world observational study designed to enroll
all patients eligible for enrollment. Basic data, treatment methods, postoperative
complications and limb function were collected. The differences in postoperative
complications, postoperative limb function and so on between patients who underwent LARS
ligament implantation and bone prosthesis replacement (ligament group) and patients who
underwent bone prosthesis replacement (control group) were compared.
Detailed description:
This is a single-center prospective real-world observational study of 100 eligible
patients with bone tumors who are scheduled to undergo LARS ligament implantation and/or
bone prosthesis replacement in Henan Cancer Hospital in the next 10 years. Basic data,
treatment methods, postoperative complications and limb function were collected. The
differences in postoperative complications, postoperative limb function and so on between
patients who underwent LARS ligament implantation and bone prosthesis replacement
(ligament group) and patients who underwent bone prosthesis replacement (control group)
were compared.
Criteria for eligibility:
Study pop:
Patients undergoing LARS ligament and bone prosthesis replacement
Sampling method:
Non-Probability Sample
Criteria:
Inclusion Criteria:
Men and women of all ages are welcome.
Pathologically confirmed in our hospital as a subtype of malignant tumor.
He received LARS ligament and bone prosthesis replacement at our hospital.
Exclusion Criteria:
Not Applicable.
Gender:
All
Minimum age:
N/A
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
Department of Bone and Soft Tissue ,Henan Cancer Hospital
Address:
City:
Zhengzhou
Country:
China
Contact:
Last name:
Tian Zhichao, Dr.
Phone:
+8618737187831
Email:
tianzhichhaoyy@163.com
Start date:
December 30, 2024
Completion date:
February 28, 2032
Lead sponsor:
Agency:
Henan Cancer Hospital
Agency class:
Other
Source:
Henan Cancer Hospital
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05616182
